A wave of panic and confusion has spread through Indian communities and the global tech industry, following US President ...

The Indian government said Trump's new H-1B visa fees could hinder talent mobility and impact Indian families.

U.S. Secretary of State Marco Rubio stressed the critical importance of the U.S. relationship with India on Monday, after ...

The tariff blitz continues. Donald Trump has now imposed a 100 per cent duty on pharmaceutical drugs from October 1. This ...

Donald Trump's pharma tariff threat could hit India’s $30 billion drug exports, unsettling the generics market that supplies 90% of US prescriptions.

India supplies over 45 per cent of generic drugs and 15 per cent of biosimilars used in the US. Major Indian firms such as Dr ...

WASHINGTON — President Donald Trump hosted Pakistan’s prime minister, Shehbaz Sharif, for talks Thursday at the White House ...

The announcement comes amid ongoing negotiations between the US and India over a trade deal. India already faces 50% tariffs, ...

Like always, the tariffs were announced in a post on his social media platform Truth Social. In wake of these tariffs, shares ...

U.S. President Donald Trump announces 100% tariff on branded pharmaceutical imports, pushing for U.S. manufacturing, impacting India's $20 billion industry.

Trump posted on his Truth Social that there would be no levies on pharmaceutical imports if companies have broken ground on a ...

For now, experts say that India’s generic drug exports remain largely safe, though any future extension of US tariffs to generics could disrupt the sector and investor sentiment.